TOI,HIMS,LFMD,AIRS,TDOC Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.05
Percentage change -1.34	%

Peers: AMGN BMY PFE MRK LLY AZN GILD REGN VRTX BIIB

| Held by: VTI IWM VXF IWO VTWO IWC GSSC VTWG RSSL OMFS

Index	RUT	P/E	-	EPS (ttm)	-0.68	Insider Own	50.57%	Shs Outstand	93.28M	Perf Week	0.54%
Market Cap	345.03M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	-6.34%	Shs Float	46.22M	Perf Month	-0.54%
Enterprise Value	417.90M	PEG	-	EPS next Q	-0.12	Inst Own	27.86%	Short Float	11.89%	Perf Quarter	37.94%
Income	-54.12M	P/S	0.81	EPS this Y	23.00%	Inst Trans	18.87%	Short Ratio	2.62	Perf Half Y	312.80%
Sales	424.38M	P/B	-	EPS next Y	61.59%	ROA	-31.89%	Short Interest	5.50M	Perf YTD	1094.17%
Book/sh	-0.10	P/C	11.39	EPS next 5Y	-	ROE	-535.24%	52W High	4.50 -18.00%	Perf Year	1028.44%
Cash/sh	0.32	P/FCF	-	EPS past 3/5Y	-62.37% -488.57%	ROIC	-62.05%	52W Low	0.13 2844.93%	Perf 3Y	-45.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	24.68% -	Gross Margin	13.40%	Volatility	8.15% 8.23%	Perf 5Y	-63.28%
Dividend TTM	-	EV/Sales	0.98	EPS Y/Y TTM	14.49%	Oper. Margin	-11.05%	ATR (14)	0.31	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.37	Sales Y/Y TTM	17.53%	Profit Margin	-12.75%	RSI (14)	49.93	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.62	EPS Q/Q	11.50%	SMA20	-5.18%	Beta	0.14	Target Price	7.00
Payout	-	Debt/Eq	-	Sales Q/Q	21.53%	SMA50	15.21%	Rel Volume	0.47	Prev Close	3.74
Employees	825	LT Debt/Eq	-	Earnings	Aug 13 AMC	SMA200	117.15%	Avg Volume	2.10M	Price	3.69
IPO	Jun 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-25.00% 5.72%	Trades		Volume	995,378	Change	-1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-23-25	Initiated	Noble Capital Markets	Outperform	$8
Jul-16-25	Initiated	B. Riley Securities	Buy	$6
May-15-25	Initiated	BTIG Research	Buy	$7
Feb-26-24	Resumed	Jefferies	Buy	$2.50
Sep-14-22	Initiated	Guggenheim	Buy	$7
Aug-15-22	Initiated	Jefferies	Buy	$10

Aug-18-25 08:00AM	The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida (GlobeNewswire) +7.45%
Aug-14-25 03:14AM	The Oncology Institute Inc (TOI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) -10.49%
Aug-13-25 04:05PM	The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire)
04:04PM	The Oncology Institute Announces Changes to Board of Directors (GlobeNewswire)
Jul-24-25 04:05PM	The Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire)
04:05PM	Loading…
Jul-14-25 04:05PM	The Oncology Institute Names Kristin England as Chief Administrative Officer (GlobeNewswire) -7.48%
Jul-09-25 07:20AM	The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members (Insider Monkey)
Jun-30-25 04:05PM	The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada (GlobeNewswire) -6.39% +7.32%
Jun-03-25 08:00AM	The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
May-14-25 04:06PM	The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance (GlobeNewswire) -10.57% +28.27%
04:05PM	The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer (GlobeNewswire)
May-13-25 07:08PM	Topicus.com Inc. Announces Election of Members of the Board of Directors (GlobeNewswire)
04:05PM	The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference (GlobeNewswire)
May-08-25 08:00AM	The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates (GlobeNewswire) +6.18%
May-07-25 05:03PM	Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 (GlobeNewswire) +5.36%
05:48PM	Loading…
May-01-25 05:48PM	Topicus.com Inc. Defers Release Date for First Quarter Results (GlobeNewswire) +12.50%
Apr-30-25 06:04AM	Why The Oncology Institute, Inc. (TOI) is Surging in 2025 (Insider Monkey)
Apr-26-25 11:00AM	Microsoft, Apple Set To Report Earnings As Markets Watch Out For Core PCE Price Index (Seeking Alpha)
Apr-23-25 08:00AM	The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call (GlobeNewswire) +6.27%
Apr-22-25 04:05PM	The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials (GlobeNewswire) +13.39%
Apr-01-25 10:04AM	The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey) +10.53%
Mar-31-25 08:00AM	TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 (GlobeNewswire)
Mar-26-25 03:02AM	The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... (GuruFocus.com)
Mar-25-25 06:28PM	The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript (SeekingAlpha)
Mar-24-25 09:05AM	Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result (GuruFocus.com) +24.47%
06:01AM	The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 (GlobeNewswire)
06:00AM	The Oncology Institute Announces $16.5 million Private Placement (GlobeNewswire)
Mar-04-25 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-25 08:00AM	The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown (GlobeNewswire) +19.66%
Dec-18-24 04:05PM	Florida Blue enhances cancer care for thousands of members (GlobeNewswire) +11.12%
04:05PM	Loading…
Nov-13-24 04:05PM	The Oncology Institute Reports Third Quarter 2024 Financial Results (GlobeNewswire) -9.03% -10.84%
Nov-11-24 08:00AM	The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California (GlobeNewswire)
Nov-04-24 07:09PM	The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire) -6.64%
Oct-23-24 08:00AM	The Oncology Institute Joins Lantern's Cancer Care Network of Excellence (GlobeNewswire)
Oct-14-24 08:00AM	The American Journal of Managed Care and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care (GlobeNewswire)
Sep-30-24 08:00AM	The Oncology Institute of Hope & Innovation Launches Oregon Market (GlobeNewswire) +5.59%
Sep-23-24 08:00AM	The Oncology Institute Announces CFO Transition (GlobeNewswire)
Aug-13-24 04:05PM	The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance (GlobeNewswire) +13.40% -18.18%
Jul-23-24 08:00AM	The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
May-29-24 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-22-24 08:00AM	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference (GlobeNewswire)
May-15-24 03:14AM	The Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -24.00%
May-14-24 06:05PM	The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance (GlobeNewswire)
May-07-24 04:05PM	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit (GlobeNewswire) -6.08%
Apr-23-24 08:00AM	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-08-24 08:00AM	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute (GlobeNewswire) +6.00%
Apr-04-24 08:00AM	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California (GlobeNewswire)
Apr-01-24 01:35PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-27-24 08:52PM	TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +8.88% -14.13%
05:34PM	The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 (GlobeNewswire)
Mar-21-24 09:35AM	Down -23.64% in 4 Weeks, Here's Why The Oncology Institute (TOI) Looks Ripe for a Turnaround (Zacks)
Mar-14-24 08:09AM	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership (GlobeNewswire) +5.62%
Mar-06-24 08:00AM	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-27-24 04:05PM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-20-24 08:00AM	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model (GlobeNewswire)
Jan-25-24 08:00AM	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio (GlobeNewswire)
Dec-04-23 08:00AM	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California (GlobeNewswire)
Nov-16-23 05:04AM	Insider Sell Alert: Director Brad Hively Sells 47,000 Shares of The Oncology Institute Inc (TOI) (GuruFocus.com) -7.21%
Nov-11-23 12:43PM	The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:50PM	The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens (GuruFocus.com) +5.75% +27.72%
04:05PM	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Oct-18-23 08:03AM	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-11-23 04:05PM	The Oncology Institute Names Jeremy Castle as Chief Operations Officer (GlobeNewswire)
Sep-26-23 04:05PM	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit (GlobeNewswire)
Sep-18-23 08:00AM	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Aug-09-23 08:10AM	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology (GlobeNewswire)
Aug-08-23 04:40PM	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
Aug-02-23 06:16AM	Oncology Institute (NASDAQ:TOI) shareholders have endured a 90% loss from investing in the stock three years ago (Simply Wall St.) -5.71%
Jul-31-23 08:00AM	The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations (GlobeNewswire)
Jul-18-23 08:00AM	The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jun-12-23 06:00AM	The Oncology Institute Announces Leadership Transition (GlobeNewswire) -9.02%
Jun-09-23 08:00AM	The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research (GlobeNewswire) -5.31%
Jun-07-23 08:00AM	The Oncology Institute to Open Project Southland (GlobeNewswire) +17.07%
May-31-23 08:01AM	The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting (GlobeNewswire)
08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
May-10-23 04:05PM	The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance (GlobeNewswire)
May-04-23 11:47AM	The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education (PR Newswire)
May-02-23 08:00AM	TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer (GlobeNewswire) -6.51%
Apr-19-23 08:00AM	The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Mar-16-23 08:08PM	CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -12.41% -17.07%
Mar-09-23 04:20PM	The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023 (GlobeNewswire) -11.35% -19.60%
Feb-28-23 08:00AM	The Oncology Institute to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-16-23 08:00AM	The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Dec-19-22 08:00AM	The Oncology Institute Expands Into Chino, CA (GlobeNewswire)
Dec-15-22 08:00AM	The Oncology Institute Rebrands Clinical Trials Division (GlobeNewswire) -7.26%
Nov-22-22 08:00AM	The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa (GlobeNewswire) +5.70%
Nov-09-22 04:05PM	The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance (GlobeNewswire) -5.16%
Nov-01-22 08:00AM	The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference (GlobeNewswire) -8.59%
Oct-19-22 08:00AM	The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call (GlobeNewswire)
Oct-17-22 04:05PM	The Oncology Institute Executives to Speak at Key Industry Conferences in Q4 (GlobeNewswire) +6.08%
Oct-11-22 08:00AM	The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials (GlobeNewswire) +5.37%
Oct-06-22 08:00AM	The Oncology Institute Expands into South Florida (GlobeNewswire)
Sep-29-22 08:00AM	The Oncology Institute Enrolls Nations First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib (GlobeNewswire)
Sep-22-22 04:05PM	The Oncology Institute Appoints Two New Board Members (GlobeNewswire)
Sep-15-22 08:00AM	The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium (GlobeNewswire) -7.62%
Sep-12-22 08:00AM	The Oncology Institute Becomes Certified as a Patient Safety Organization (GlobeNewswire)
Aug-22-22 08:00AM	The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms (GlobeNewswire)
Aug-16-22 08:00AM	The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day (GlobeNewswire) +9.21%

The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hively Brad	Director	Aug 19 '25	Sale	4.06	20,221	82,097	622,980	Aug 21 03:13 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	673,676	2,054,712	13,950,557	Jun 09 04:15 PM
M33 Growth I L.P.	Director	Jun 05 '25	Sale	3.05	76,324	232,788	1,272,724	Jun 09 04:15 PM
Hively Brad	Director	Jun 03 '25	Option Exercise	0.90	1,867,605	1,682,524	2,579,638	Jun 05 06:51 PM
Hively Brad	Director	Jun 03 '25	Sale	2.87	1,976,137	5,672,106	603,501	Jun 05 06:51 PM
TOI M, LLC	10% Owner	Jun 05 '25	Proposed Sale	3.20	127,207	407,062		Jun 05 06:17 PM
M33 Growth I L.P.	10% Owner	Jun 05 '25	Proposed Sale	3.20	1,122,793	3,592,938		Jun 05 06:13 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	39,600	113,652		Jun 03 05:08 PM
BRADFORD DANIEL HIVELY	Director	Jun 03 '25	Proposed Sale	2.87	1,936,537	5,557,861		Jun 03 04:27 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	1,796,468	4,873,638	14,624,233	May 22 07:38 PM
M33 Growth I L.P.	Director	May 20 '25	Sale	2.71	203,532	552,162	1,349,048	May 22 07:38 PM
TOI M, LLC	10% Owner	May 20 '25	Proposed Sale	3.06	203,532	622,808		May 20 06:25 PM
M33 Growth I L.P.	10% Owner	May 20 '25	Proposed Sale	3.06	1,796,468	5,497,192		May 20 06:19 PM
Virnich Daniel	Chief Executive Officer	Mar 26 '25	Buy	1.04	22,640	23,584	724,363	Mar 28 05:50 PM
Podnos Yale	Chief Medical Officer	Mar 26 '25	Buy	1.04	9,056	9,434	79,049	Mar 28 05:48 PM
Pacala Mark L	Director	Mar 26 '25	Buy	1.04	90,562	94,338	224,971	Mar 28 05:41 PM
Johnson Karen Marie	Director	Mar 26 '25	Buy	1.04	36,224	37,735	203,409	Mar 28 05:36 PM
Hively Brad	Director	Mar 26 '25	Buy	1.04	9,056	9,434	675,809	Mar 28 05:34 PM
Castle Jeremy	Chief Operating Officer	Mar 26 '25	Buy	1.04	9,056	9,434	90,386	Mar 28 05:33 PM
Carter Robert Ross	Chief Financial Officer	Mar 26 '25	Buy	1.04	9,056	9,434	39,407	Mar 28 05:27 PM
BARASCH RICHARD A	Director	Mar 26 '25	Buy	1.04	1,358,448	1,415,095	1,775,641	Mar 28 05:25 PM
Hively Brad	Director	Nov 26 '24	Buy	0.17	250,000	42,500	616,753	Dec 02 04:04 PM
Hively Brad	Director	Dec 02 '24	Buy	0.15	50,000	7,500	666,753	Dec 02 04:04 PM

Dollar change +0.58
Percentage change 1.34	%

HIMS Hims & Hers Health Inc daily Stock Chart

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: VTI VB IJH IWM VBK VXF IWO MDY XMHQ VTWO

Index	RUT	P/E	55.02	EPS (ttm)	0.80	Insider Own	10.36%	Shs Outstand	217.38M	Perf Week	-6.73%
Market Cap	9.94B	Forward P/E	55.38	EPS next Y	0.79	Insider Trans	-9.29%	Shs Float	201.50M	Perf Month	-24.23%
Enterprise Value	9.84B	PEG	2.15	EPS next Q	0.10	Inst Own	77.95%	Short Float	32.06%	Perf Quarter	-24.21%
Income	193.60M	P/S	4.93	EPS this Y	7.87%	Inst Trans	3.03%	Short Ratio	1.65	Perf Half Y	-33.81%
Sales	2.01B	P/B	17.64	EPS next Y	38.84%	ROA	16.42%	Short Interest	64.59M	Perf YTD	81.80%
Book/sh	2.49	P/C	8.68	EPS next 5Y	25.56%	ROE	41.88%	52W High	72.98 -39.76%	Perf Year	165.46%
Cash/sh	5.06	P/FCF	85.31	EPS past 3/5Y	- 17.22%	ROIC	12.07%	52W Low	13.47 226.35%	Perf 3Y	531.61%
Dividend Est.	-	EV/EBITDA	59.23	Sales past 3/5Y	75.77% -	Gross Margin	67.11%	Volatility	5.19% 6.74%	Perf 5Y	308.93%
Dividend TTM	-	EV/Sales	4.88	EPS Y/Y TTM	947.74%	Oper. Margin	6.80%	ATR (14)	3.44	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.46	Sales Y/Y TTM	88.69%	Profit Margin	9.62%	RSI (14)	37.14	Recom	2.56
Dividend Gr. 3/5Y	- -	Current Ratio	4.98	EPS Q/Q	198.06%	SMA20	-16.89%	Beta	2.17	Target Price	50.66
Payout	0.00%	Debt/Eq	1.86	Sales Q/Q	72.61%	SMA50	-15.53%	Rel Volume	0.70	Prev Close	43.38
Employees	1637	LT Debt/Eq	1.85	Earnings	Aug 04 AMC	SMA200	9.06%	Avg Volume	39.10M	Price	43.96
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.73% -1.24%	Trades		Volume	27,496,472	Change	1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5

Show Previous Ratings

Today 02:53PM	Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term (Motley Fool)
09:05AM	Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets (MarketBeat)
Aug-20-25 12:33AM	Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook (Insider Monkey)
Aug-19-25 04:50PM	Why Hims & Hers Health (HIMS) Stock Is Falling Today (StockStory) -6.47%
04:43PM	Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025 - Contact Levi & Korsinsky (Newsfile)
10:01AM	Loading…
10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks)
Aug-18-25 07:04PM	Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 (MarketBeat)
01:00PM	Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisks breakup with Hims (FastCompany)
12:34PM	Wegovy News Pushes Novo Nordisk Stock Higher (Barrons.com)
12:18PM	Meta's reported shake-up, Hims & Hers sinks on GoodRxNovo deal (Yahoo Finance Video)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:00AM	GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month (Yahoo Finance)
09:00AM	GoodRx begins selling Novo Nordisk GLP-1s for cash price (Yahoo Finance)
09:00AM	Novo Nordisk Stock Is Jumping. The Good News Pushing Shares Higher. (Barrons.com)
07:27AM	Stock Market Today: All's quiet on the Wyoming front (TheStreet)
03:58AM	Loading…
03:58AM	Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market (Pharma Voice)
Aug-15-25 04:45PM	Draft of Trumps Health Blueprint Avoids Industry Crackdown (Bloomberg)
08:48AM	Big Pharma Has a New Vision for Selling Drugs. It's Going to the Mattresses. (Barrons.com)
08:43AM	HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge (GuruFocus.com)
Aug-14-25 04:48PM	Hims & Hers stock drops after FTC probe report (Investing.com)
03:24PM	HIMS CEO Family Trust Sells $33M Shares Following Novo Nordisk Accusations - Hagens Berman (Newsfile)
08:35AM	Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics (Zacks)
Aug-13-25 02:16PM	3 Unusual Insider Transactions you Should Know About (Zacks)
12:51PM	Hims & Hers (HIMS) Falls as Key Executives Dispose Shares (Insider Monkey)
12:43PM	Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
12:36AM	1 Mid-Cap Stock with Competitive Advantages and 2 We Avoid (StockStory)
12:13AM	The Top 5 Analyst Questions From Hims & Hers Health's Q2 Earnings Call (StockStory)
12:05AM	HIMS Q2 Deep Dive: International Expansion and Product Shifts Define Next Growth Phase (StockStory)
Aug-12-25 03:45PM	Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today (StockStory)
03:21PM	Loading…
03:21PM	Hims & Hers CEO sells $33 million in stock after a massive rally (MarketWatch)
12:12PM	Hims & Hers Drives the Consumer-Centric Transformation in Digital Care (Zacks)
Aug-11-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
10:00AM	Where Will Hims & Hers Be in 5 Years? (Motley Fool)
09:05AM	Novo ramps up lawsuits over Wegovy copies - but not for Hims & Hers (Reuters Videos)
09:00AM	Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? (Zacks)
06:09AM	As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? (Reuters)
Aug-10-25 04:35AM	Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills? (Motley Fool)
Aug-09-25 07:00AM	MarketBeat Week in Review - 08/04 - 08/08 (MarketBeat)
06:32AM	Why Hims & Hers Stock Sank This Week (Motley Fool)
Aug-08-25 04:22PM	Capital Compounders for Investors (Motley Fool)
12:48PM	Hims Stock Gets Booted Off IBD 50 While Other Volatile Names Hang On (Investor's Business Daily)
11:00AM	MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025 (PR Newswire)
Aug-07-25 07:00PM	Hims & Hers: A Game-Changer in Telehealth or Just Another Fad? (Motley Fool)
05:27PM	Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 (Newsfile)
10:51AM	Hims & Hers Redefines Virtual Care With Integrated Tech Platforms (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
12:46AM	2 Surging Stocks to Research Further and 1 We Turn Down (StockStory)
Aug-06-25 04:52PM	Novo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, Ozempic (Investor's Business Daily) -7.91%
02:04PM	Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO (Yahoo Finance)
12:24PM	Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues (Insider Monkey)
09:16AM	Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy (Investor's Business Daily)
08:42AM	Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy (MarketBeat)
07:05AM	These Are the Smartest Growth Stocks to Invest $1,000 in Today (Motley Fool)
05:54AM	AI and GLP-1s were the hot post-pandemic trades, but only one is thriving (Yahoo Finance)
Aug-05-25 05:15PM	Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer (The Wall Street Journal) -12.36%
04:44PM	These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More (Barrons.com)
04:20PM	Why Hims Stock Plunged And Why It Could Still Remain A 'Market Darling' (Investor's Business Daily)
01:26PM	Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem. (Barrons.com)
11:40AM	HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down (Zacks)
11:07AM	Why Hims & Hers Health Stock Just Dropped (Motley Fool)
11:06AM	Hims & Hers Health, DuPont, Gartner: Trending Tickers (Yahoo Finance Video)
11:03AM	Why Did Hims & Hers Stock Crash and Then Recover After Earnings? (Motley Fool)
09:58AM	Hims & Hers stock slides 5% after second quarter revenue misses forecasts (Yahoo Finance)
09:38AM	Stocks to Watch Tuesday: Hims, Pfizer, Caterpillar, TSMC (The Wall Street Journal)
09:15AM	3 Stocks to Hold for 20 Years (Motley Fool)
08:47AM	Stock Market Today: Dow Rises Ahead Of Key Data; Palantir Surges On Earnings (Live Coverage) (Investor's Business Daily)
08:45AM	Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth (GuruFocus.com)
08:34AM	Novo Nordisk Stock Sinks-But Is a Bottom Finally In? (MarketBeat)
07:44AM	Stocks to Watch Tuesday: Palantir, Hims, Pfizer, Caterpillar (The Wall Street Journal)
07:27AM	These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More (Barrons.com)
06:46AM	The post-Figma question: Whos next? (Fortune)
06:13AM	US stock futures higher amid mixed corporate earnings (USA TODAY)
05:08AM	These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More (Barrons.com)
03:05AM	Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ... (GuruFocus.com)
Aug-04-25 06:19PM	Him & Hers Health report Q2 earnings, missing revenue estimates (CNBC TV)
06:18PM	Selloff? What Selloff? Monday Market Rebound (Zacks)
05:48PM	Stocks to Watch Monday: Palantir, Hims & Hers, Vertex, Tesla (The Wall Street Journal)
05:45PM	Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates (Zacks)
05:36PM	Hims & Hers, ThredUp, MercadoLibre: After-hours trending stocks (Yahoo Finance Video)
05:21PM	Hims & Hers Health Stock Stumbles After Earnings. Here's Why. (Barrons.com)
05:15PM	Hims & Hers sees 'an exciting period of growth,' but stock falls (MarketWatch)
05:10PM	Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles (Yahoo Finance)
05:07PM	IBD 50's Hims & Hers Plummets By Double Digits. Is The Obesity Business In Trouble? (Investor's Business Daily)
04:59PM	Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12% (StockStory)
04:50PM	Hims & Hers slides after Q2 revenue miss, cautious guidance amid GLP-1 scrutiny (Investing.com)
04:40PM	Hims & Hers Health Reports Higher Profit, Revenue (The Wall Street Journal)
04:23PM	IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss (Investor's Business Daily)
04:05PM	Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results (Business Wire)
03:32PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
08:26AM	Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings (GuruFocus.com)
04:23AM	McDonalds Earnings, New Tariff Deadline, PMIs: What to Watch This Week (The Wall Street Journal)
Aug-03-25 03:29PM	2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run (Motley Fool)
07:36AM	Job market concerns take center stage as earnings season rolls on: What to watch this week (Yahoo Finance)
Aug-02-25 11:07PM	What To Expect From Hims & Hers Health's (HIMS) Q2 Earnings (StockStory)
Aug-01-25 06:15PM	Earnings, Fed commentary, consumer credit: What to Watch (Yahoo Finance Video) -5.49%
05:07PM	Will Hims & Hers Fall Along With Novo Nordisk? (MarketBeat)
04:38PM	McDonalds, Palantir, Novo Nordisk Earnings: What to Watch Next Week (The Wall Street Journal)
01:35PM	Trump's Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem. (Barrons.com)
12:18PM	Hims & Hers Stock to Report Q2 Earnings: What's in the Cards? (Zacks)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Option Exercise	11.53	250	2,882	278,904	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Sale	67.00	26,350	1,765,450	278,654	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Sale	64.44	250	16,110	278,654	Aug 04 04:21 PM
Chi Michael	Officer	Aug 01 '25	Proposed Sale	64.44	250	16,110		Aug 01 11:12 AM
Chi Michael	Officer	Jul 31 '25	Proposed Sale	67.00	26,350	1,765,450		Jul 31 11:02 AM
Boughton Soleil	Chief Legal Officer	Jul 28 '25	Sale	58.70	2,572	150,976	155,593	Jul 29 04:25 PM
Boughton Soleil	Officer	Jul 28 '25	Proposed Sale	58.70	2,572	150,976		Jul 28 12:59 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Option Exercise	5.25	13,750	72,146	292,404	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Option Exercise	5.01	2,100	10,521	280,754	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Sale	56.00	13,750	770,000	278,654	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Sale	57.52	2,100	120,792	278,654	Jul 25 05:20 PM
Chi Michael	Officer	Jul 24 '25	Proposed Sale	57.52	2,100	120,792		Jul 24 10:44 AM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Option Exercise	2.43	125,335	304,564	142,313	Jul 23 04:12 PM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Sale	49.54	125,335	6,208,637	92,313	Jul 23 04:12 PM
Chi Michael	Officer	Jul 23 '25	Proposed Sale	56.00	13,750	770,000		Jul 23 12:19 PM
Melissa Baird	Officer	Jul 21 '25	Proposed Sale	47.60	33,333	1,586,651		Jul 21 04:59 PM
Dudum Andrew	Officer	Jul 21 '25	Proposed Sale	49.54	125,335	6,208,636		Jul 21 10:41 AM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.25	47,534	2,388,817	190,126	Jul 18 04:29 PM
Dudum Andrew	Chief Executive Officer	Jul 16 '25	Sale	50.58	2,792	141,217	92,313	Jul 18 04:29 PM
Dudum Andrew	Officer	Jul 16 '25	Proposed Sale	50.27	50,326	2,530,033		Jul 16 11:49 AM
Boughton Soleil	Chief Legal Officer	Jul 14 '25	Sale	47.82	2,572	122,993	158,165	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Option Exercise	5.01	7,587	38,011	65,665	Jul 15 04:28 PM
Okupe Oluyemi	Chief Financial Officer	Jul 14 '25	Sale	47.70	11,581	552,418	54,084	Jul 15 04:28 PM
Boughton Soleil	Officer	Jul 14 '25	Proposed Sale	47.82	2,572	122,993		Jul 14 12:25 PM
Melissa Baird	Officer	Jul 08 '25	Proposed Sale	48.96	33,333	1,631,984		Jul 08 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Option Exercise	5.01	6,437	32,249	69,659	Jul 08 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jul 07 '25	Sale	46.67	11,581	540,498	58,078	Jul 08 04:40 PM
Boughton Soleil	Chief Legal Officer	Jun 30 '25	Sale	50.50	2,572	129,886	160,737	Jul 01 04:45 PM
Boughton Soleil	Officer	Jun 30 '25	Proposed Sale	50.50	2,572	129,886		Jun 30 10:56 AM
Okupe Oluyemi	Chief Financial Officer	Jun 23 '25	Sale	47.25	23,107	1,091,766	63,222	Jun 24 04:31 PM
Oluyemi Okupe	Officer	Jun 23 '25	Proposed Sale	41.98	69,431	2,914,713		Jun 23 04:49 PM
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM
Melissa Baird	Officer	Jun 16 '25	Proposed Sale	59.78	33,333	1,992,647		Jun 16 05:58 PM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.49	47,534	2,685,348		Jun 16 02:42 PM
Boughton Soleil	Officer	Jun 16 '25	Proposed Sale	56.80	5,451	309,617		Jun 16 11:53 AM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.43	128,127	7,230,643		Jun 16 11:24 AM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Option Exercise	6.82	5,400	36,828	261,980	Jun 11 08:09 PM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Sale	57.00	5,600	319,200	256,380	Jun 11 08:09 PM
Chi Michael	Officer	Jun 10 '25	Proposed Sale	57.00	5,400	307,800		Jun 10 12:12 PM
Chi Michael	Chief Commercial Officer	Jun 05 '25	Option Exercise	13.90	28,776	399,986	256,580	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Option Exercise	13.20	5,100	67,335	260,180	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Sale	56.00	5,100	285,600	256,580	Jun 09 04:58 PM
Chi Michael	Officer	Jun 06 '25	Proposed Sale	56.00	5,100	285,600		Jun 06 01:19 PM
Melissa Baird	Officer	Jun 04 '25	Proposed Sale	53.61	33,333	1,786,982		Jun 04 04:46 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Option Exercise	5.01	6,437	32,249	120,253	May 30 04:28 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Sale	52.98	11,581	613,537	39,153	May 30 04:28 PM
Boughton Soleil	Chief Legal Officer	May 27 '25	Sale	55.87	3,233	180,628	153,194	May 29 05:56 PM
Becklund Irene	PAO	May 22 '25	Sale	53.51	5,071	271,349	0	May 27 04:59 PM
Melissa Baird	Officer	May 27 '25	Proposed Sale	53.36	33,333	1,778,649		May 27 04:44 PM
Boughton Soleil	Officer	May 27 '25	Proposed Sale	55.87	3,233	180,628		May 27 11:12 AM
Becklund Irene	Officer	May 22 '25	Proposed Sale	53.51	5,071	271,349		May 22 09:45 AM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Option Exercise	10.97	6,437	70,646	125,397	May 19 06:35 PM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Sale	60.22	11,581	697,462	113,816	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Option Exercise	2.43	125,335	304,564	197,645	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.40	128,127	7,482,414	89,311	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.25	47,534	2,768,974	285,194	May 19 06:35 PM
Dudum Andrew	Officer	May 16 '25	Proposed Sale	58.36	175,661	10,251,390		May 16 11:08 AM
Baird Melissa	Chief Operating Officer	May 12 '25	Option Exercise	2.43	33,333	80,999	838,416	May 13 05:07 PM
Baird Melissa	Chief Operating Officer	May 12 '25	Sale	56.02	33,333	1,867,376	805,083	May 13 05:07 PM
Boughton Soleil	Chief Legal Officer	May 12 '25	Sale	56.00	3,235	181,160	156,427	May 13 05:07 PM
Melissa Baird	Officer	May 12 '25	Proposed Sale	55.21	33,333	1,840,315		May 12 05:10 PM
Boughton Soleil	Officer	May 12 '25	Proposed Sale	56.00	3,235	181,160		May 12 10:25 AM
Boughton Soleil	Chief Legal Officer	Apr 28 '25	Sale	30.19	3,236	97,695	159,662	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Option Exercise	2.43	50,000	121,500	142,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Option Exercise	2.43	41,667	101,251	133,770	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Sale	36.39	50,000	1,819,310	92,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Sale	30.19	41,667	1,257,760	92,103	Apr 30 06:01 PM
Dudum Andrew	Officer	Apr 29 '25	Proposed Sale	36.39	50,000	1,819,309		Apr 29 10:51 AM
Dudum Andrew	Officer	Apr 28 '25	Proposed Sale	30.19	41,667	1,257,753		Apr 28 12:51 PM
Boughton Soleil	Officer	Apr 28 '25	Proposed Sale	30.19	3,236	97,695		Apr 28 10:07 AM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM

Dollar change +0.10
Percentage change 1.62	%

Peers: HIMS CVS TDOC AMWL DOCS LFST SEM AMED EHC CHE

| Held by: VTI IWM VXF KOMP VTWO IWO JSMD DWAS PTH IWN

Index	RUT	P/E	-	EPS (ttm)	-0.21	Insider Own	19.98%	Shs Outstand	45.04M	Perf Week	-4.70%
Market Cap	298.25M	Forward P/E	26.69	EPS next Y	0.24	Insider Trans	-4.58%	Shs Float	37.94M	Perf Month	-42.03%
Enterprise Value	286.23M	PEG	-	EPS next Q	-0.04	Inst Own	50.61%	Short Float	11.66%	Perf Quarter	-41.60%
Income	-9.03M	P/S	1.21	EPS this Y	80.32%	Inst Trans	8.00%	Short Ratio	2.19	Perf Half Y	-16.36%
Sales	245.56M	P/B	-	EPS next Y	326.03%	ROA	-8.63%	Short Interest	4.43M	Perf YTD	27.07%
Book/sh	-0.04	P/C	8.23	EPS next 5Y	-	ROE	-	52W High	15.84 -60.29%	Perf Year	18.23%
Cash/sh	0.76	P/FCF	16.67	EPS past 3/5Y	38.43% -10.98%	ROIC	-116.30%	52W Low	3.99 57.64%	Perf 3Y	130.40%
Dividend Est.	-	EV/EBITDA	33.48	Sales past 3/5Y	31.76% 76.32%	Gross Margin	82.71%	Volatility	5.88% 7.77%	Perf 5Y	-37.10%
Dividend TTM	-	EV/Sales	1.17	EPS Y/Y TTM	69.79%	Oper. Margin	-0.83%	ATR (14)	0.73	Perf 10Y	562.11%
Dividend Ex-Date	-	Quick Ratio	0.72	Sales Y/Y TTM	37.74%	Profit Margin	-3.68%	RSI (14)	31.52	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	0.77	EPS Q/Q	65.35%	SMA20	-23.72%	Beta	1.60	Target Price	12.88
Payout	-	Debt/Eq	-	Sales Q/Q	22.81%	SMA50	-41.43%	Rel Volume	0.48	Prev Close	6.19
Employees	336	LT Debt/Eq	-	Earnings	Aug 05 AMC	SMA200	-17.08%	Avg Volume	2.02M	Price	6.29
IPO	Oct 21, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	-622.89% -6.21%	Trades		Volume	963,542	Change	1.62%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-18-25	Reiterated	BTIG Research	Buy	$15 → $18
Dec-10-24	Initiated	Lake Street	Buy	$12
Dec-04-24	Initiated	Mizuho	Neutral	$7
Aug-23-24	Resumed	B. Riley Securities	Buy	$11
Jun-05-24	Initiated	KeyBanc Capital Markets	Overweight	$12
Nov-30-23	Initiated	Craig Hallum	Buy	$10
Jul-21-23	Initiated	Cantor Fitzgerald	Overweight	$7
Jul-03-23	Initiated	H.C. Wainwright	Buy	$9
Mar-10-22	Initiated	Colliers Securities	Buy	$14
Oct-04-21	Resumed	B. Riley Securities	Buy	$16

Aug-19-25 10:01AM	Hims & Hers Fuels Growth via Market Expansion and New Care Verticals (Zacks) -6.22%
Aug-18-25 09:07AM	Novo Nordisk to offer Ozempic at $499 per month to eligible US customers (Reuters)
Aug-06-25 10:29AM	LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. (Investor's Business Daily) -44.85%
Aug-05-25 06:05PM	LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	LifeMD Reports Second Quarter 2025 Results (GlobeNewswire)
04:05PM	Loading…
Aug-04-25 04:05PM	Medifast Announces Second Quarter 2025 Financial Results (Business Wire) +24.25%
09:59AM	LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
08:00AM	LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-31-25 01:13PM	Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare (Zacks)
08:00AM	LifeMD Names COO and Promotes Two Executives (GlobeNewswire)
Jul-29-25 04:05PM	LifeMD to Report Second Quarter 2025 Financial Results on August 5 (GlobeNewswire) -6.16%
Jul-21-25 04:05PM	Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025 (Business Wire)
Jul-07-25 11:53AM	Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness (Zacks)
Jun-30-25 10:11AM	Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? (Zacks)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
04:51AM	Loading…
Jun-27-25 04:51AM	Novo Nordisk says WeightWatchers will sell Wegovy (Reuters Videos)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
Jun-23-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
Jun-09-25 08:00AM	LifeMD to Participate in Two Investor Conferences During June (GlobeNewswire)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily) +5.24%
May-22-25 08:05AM	LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy (GlobeNewswire) +6.78%
May-12-25 04:05PM	LifeMD to Participate in Three Investor Conferences During May (GlobeNewswire)
May-06-25 05:40PM	LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance (GlobeNewswire)
May-05-25 10:14AM	LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-30-25 05:30AM	Why New Wegovy Deals Wont Restore Novo Nordisks Obesity Lead (The Wall Street Journal) -14.62%
Apr-29-25 03:19PM	Why Hims & Hers Health and LifeMD Are Skyrocketing Today (Motley Fool) +41.31%
10:30AM	Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (Seeking Alpha)
08:05AM	Loading…
08:05AM	LifeMD Announces Plans to Expand Affordable Access to Wegovy for Cash-Pay Patients (GlobeNewswire)
Apr-28-25 04:05PM	Medifast Announces First Quarter 2025 Financial Results (Business Wire)
04:05PM	LifeMD to Report First Quarter 2025 Financial Results on May 6 (GlobeNewswire)
08:00AM	LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market (GlobeNewswire)
Apr-21-25 12:52PM	LifeMD, Inc. (LFMD): A Bull Case Theory (Insider Monkey)
Apr-17-25 08:00AM	LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs (GlobeNewswire) +8.05%
Apr-14-25 04:05PM	Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025 (Business Wire)
Apr-09-25 08:51AM	Agilon (AGL) Moves 26.1% Higher: Will This Strength Last? (Zacks) +7.88%
Apr-08-25 10:10AM	LifeMD Is Back To Life (Seeking Alpha)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-31-25 08:00AM	LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-28-25 09:21AM	Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect (Seeking Alpha)
Mar-25-25 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-11-25 03:02AM	LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions (GuruFocus.com) +30.56%
Mar-10-25 05:30PM	LifeMD Reports Fourth Quarter 2024 Results (GlobeNewswire) -8.57%
Mar-07-25 07:06AM	LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Mar-06-25 08:00AM	LifeMD Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound (GlobeNewswire)
Mar-05-25 08:00AM	LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Feb-25-25 08:05AM	LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 (GlobeNewswire) -13.11%
Feb-24-25 08:05AM	LifeMD Announces Entry Into the Behavioral Health Market (GlobeNewswire)
Jan-28-25 08:00AM	LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) +6.80%
Jan-07-25 08:30AM	Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND For GLP-1 Users and Those Looking for Help to Keep Weight Off (Business Wire)
Dec-24-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-05-24 08:30AM	Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential Even with Weight Loss Medications (Business Wire) -9.44%
08:00AM	LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution (GlobeNewswire)
Nov-12-24 08:00AM	LifeMD to Participate in Three Investor Conferences During November (GlobeNewswire)
Nov-07-24 04:05PM	LifeMD Reports Third Quarter 2024 Results (GlobeNewswire) +14.04%
Nov-06-24 08:00AM	LifeMD Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency (GlobeNewswire) +13.45%
07:45AM	Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result (GuruFocus.com)
Nov-04-24 04:05PM	Medifast Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-24-24 08:26AM	LifeMD launches TestoRx, direct to consumer testosterone replacement therapy (TipRanks)
08:00AM	LifeMD to Report Third Quarter 2024 Financial Results on November 7 (GlobeNewswire)
Oct-23-24 08:00AM	LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering (GlobeNewswire)
Sep-24-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +10.94% -9.15%
Sep-19-24 08:00AM	LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options (GlobeNewswire)
Sep-11-24 02:01PM	Medifast (MED): A Bull Case Theory (Insider Monkey) +6.45%
Aug-26-24 04:05PM	LifeMD to Participate in Three Investor Conferences During September (GlobeNewswire) -9.74%
Aug-07-24 04:05PM	LifeMD Reports Second Quarter 2024 Results (GlobeNewswire) -7.17%
Jul-30-24 08:00AM	LifeMD to Report Second Quarter 2024 Financial Results on August 7 (GlobeNewswire)
Jul-25-24 08:00AM	LifeMD to Participate in Two Investor Conferences During August (GlobeNewswire)
Jul-16-24 07:05AM	3 Overlooked Telehealth Stocks Poised for a Comeback (InvestorPlace)
Jun-25-24 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
08:00AM	LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management (GlobeNewswire)
Jun-10-24 08:00AM	LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit (GlobeNewswire)
May-29-24 08:00AM	LifeMD Set to Join the Russell 3000 Index (GlobeNewswire)
May-09-24 11:46AM	LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript (Insider Monkey) -24.57%
May-08-24 09:58PM	LFMD Stock Earnings: LifeMD Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance (GlobeNewswire)
May-02-24 08:00AM	LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition (GlobeNewswire) +7.30%
May-01-24 09:40AM	Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 08:00AM	LifeMD Appoints Dr. Calum MacRae to its Board of Directors (GlobeNewswire)
Apr-24-24 08:00AM	LifeMD to Report First Quarter 2024 Financial Results on May 8 (GlobeNewswire)
Apr-23-24 08:00AM	LifeMD to Participate in Upcoming Investor and Industry Conferences During May (GlobeNewswire) +8.90%
Mar-26-24 08:00AM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Mar-25-24 08:00AM	LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-24 05:30PM	LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.41%
04:05PM	LifeMD Reports Fourth Quarter 2023 Results (GlobeNewswire)
Feb-26-24 08:00AM	LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 (GlobeNewswire) +5.71%
Feb-15-24 08:00AM	LifeMD to Participate in Upcoming Investor Conferences and Webinar (GlobeNewswire)
Jan-31-24 08:00AM	LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Jan-18-24 08:00AM	LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference (GlobeNewswire)
Jan-08-24 08:00AM	LifeMD Provides 2024 Financial Guidance (GlobeNewswire) +6.97%
Jan-04-24 05:11PM	Why LifeMD's CEO isn't concerned about Eli Lilly's DTC site (Yahoo Finance Video) -32.05%
12:23PM	WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery (Bloomberg)
Dec-26-23 04:05PM	LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire)
Dec-13-23 05:22PM	Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its Mind (The Wall Street Journal) -6.42% +6.07%
06:01AM	Diet Company Medifast, Once an Ozempic Skeptic, Embraces Weight-Loss Drugs With New Deal (The Wall Street Journal)

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	9.99	25,000	249,690	2,475,721	Aug 05 05:14 PM
Justin Schreiber	Chairman and CEO	Aug 01 '25	Proposed Sale	10.41	175,000	1,821,750		Aug 01 04:09 PM
Schreiber Justin	Chairman and CEO	Jul 01 '25	Sale	13.38	25,000	334,458	2,500,721	Jul 03 03:53 PM
Benathen Marc David	Chief Financial Officer	Jun 16 '25	Sale	13.09	75,000	981,945	389,554	Jun 18 06:18 PM
Benathen Marc David	Chief Financial Officer	Jun 17 '25	Sale	14.01	50,000	700,495	339,554	Jun 18 06:18 PM
Yecies Eric Harold	Chief Legal Officer & GC	Jun 13 '25	Sale	12.25	15,000	183,750	16,100	Jun 17 06:12 PM
Galluppi Stefan	Chief Innovation Officer	Jun 13 '25	Sale	12.38	85,000	1,052,657	80,449	Jun 17 05:13 PM
Stefan Galluppi	Affiliate	Jun 13 '25	Proposed Sale	12.70	85,000	1,079,500		Jun 13 06:27 PM
Schreiber Justin	Chairman and CEO	Jun 02 '25	Sale	12.47	25,000	311,655	2,525,721	Jun 04 04:45 PM
Schreiber Justin	Chairman and CEO	May 01 '25	Sale	7.53	21,995	165,684	2,553,726	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	May 02 '25	Sale	7.50	3,005	22,539	2,550,721	May 05 06:02 PM
Schreiber Justin	Chairman and CEO	Apr 29 '25	Sale	7.78	50,000	389,040	2,575,721	May 01 04:47 PM
Justin Schreiber	Chairman and CEO	Apr 29 '25	Proposed Sale	8.05	125,000	1,006,250		Apr 29 04:19 PM
FRIEDEMAN JESSICA	Chief Marketing Officer	Mar 14 '25	Sale	5.66	30,000	169,665	170,000	Mar 17 06:36 PM
Schreiber Justin	Chief Executive Officer	Feb 14 '25	Sale	7.55	50,000	377,620	2,653,715	Feb 21 05:34 PM
Schreiber Justin	Chief Executive Officer	Jan 02 '25	Sale	5.19	25,000	129,668	2,703,715	Jan 06 05:33 PM
Schreiber Justin	Chief Executive Officer	Dec 02 '24	Sale	6.52	25,000	162,925	2,728,715	Dec 04 05:07 PM
Justin Schreiber	CEO	Dec 02 '24	Proposed Sale	6.60	100,000	660,000		Dec 02 05:31 PM
Galluppi Stefan	Chief Innovation Officer	Sep 11 '24	Buy	4.93	3,000	14,790	45,449	Sep 12 02:10 PM

Dollar change -0.60
Percentage change -9.24	%

AIRS Airsculpt Technologies Inc daily Stock Chart

Peers: LGVN DERM HROW VRCA PMVP RCEL TVRD DBVT BKD CDTX

| Held by: VTI IWM VXF IWO VTWO SCHA IWC IWN VTWG SCHB

Index	RUT	P/E	-	EPS (ttm)	-0.25	Insider Own	81.07%	Shs Outstand	62.44M	Perf Week	-5.61%
Market Cap	367.75M	Forward P/E	441.86	EPS next Y	0.01	Insider Trans	2.03%	Shs Float	11.82M	Perf Month	-8.68%
Enterprise Value	446.61M	PEG	-	EPS next Q	-0.02	Inst Own	28.04%	Short Float	44.83%	Perf Quarter	50.45%
Income	-14.51M	P/S	2.23	EPS this Y	-350.00%	Inst Trans	26.68%	Short Ratio	7.19	Perf Half Y	1.03%
Sales	165.11M	P/B	4.03	EPS next Y	126.67%	ROA	-7.11%	Short Interest	5.30M	Perf YTD	13.49%
Book/sh	1.46	P/C	44.90	EPS next 5Y	49.38%	ROE	-16.47%	52W High	9.20 -35.98%	Perf Year	42.96%
Cash/sh	0.13	P/FCF	-	EPS past 3/5Y	-172.08% -29.15%	ROIC	-8.75%	52W Low	1.53 284.97%	Perf 3Y	-43.83%
Dividend Est.	-	EV/EBITDA	57.26	Sales past 3/5Y	10.60% 34.33%	Gross Margin	51.34%	Volatility	7.32% 8.53%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.70	EPS Y/Y TTM	-315.81%	Oper. Margin	-2.96%	ATR (14)	0.53	Perf 10Y	-
Dividend Ex-Date	Aug 25, 2022	Quick Ratio	0.64	Sales Y/Y TTM	-14.46%	Profit Margin	-8.79%	RSI (14)	47.00	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	0.64	EPS Q/Q	82.23%	SMA20	-6.74%	Beta	2.52	Target Price	6.00
Payout	-	Debt/Eq	0.95	Sales Q/Q	-13.71%	SMA50	3.73%	Rel Volume	0.84	Prev Close	6.49
Employees	389	LT Debt/Eq	0.82	Earnings	Aug 01 BMO	SMA200	21.84%	Avg Volume	736.83K	Price	5.89
IPO	Oct 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	198.51% -3.16%	Trades		Volume	615,264	Change	-9.24%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-24	Initiated	BTIG Research	Neutral
May-14-24	Downgrade	Leerink Partners	Outperform → Market Perform	$8.25 → $5
Nov-11-22	Downgrade	Piper Sandler	Overweight → Neutral	$4
Jun-16-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $8.50
Nov-23-21	Initiated	SVB Leerink	Outperform	$26
Nov-23-21	Initiated	Raymond James	Outperform	$18
Nov-23-21	Initiated	Piper Sandler	Overweight	$22
Nov-23-21	Initiated	Morgan Stanley	Overweight	$17

Aug-19-25 08:00AM	Sidoti Events, LLC's Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-13-25 06:00AM	AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference (GlobeNewswire) +8.79%
Aug-08-25 09:40AM	Is AirSculpt Technologies (AIRS) Stock Outpacing Its Business Services Peers This Year? (Zacks)
Aug-02-25 03:07AM	AirSculpt Technologies Inc (AIRS) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Aug-01-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings Match Estimates (Zacks) -10.51%
06:00AM	Loading…
06:00AM	AirSculpt Technologies Reports Second Quarter Fiscal 2025 Results (GlobeNewswire)
Jul-31-25 09:30AM	Earnings To Watch: AirSculpt Technologies Inc (AIRS) Reports Q2 2025 Result (GuruFocus.com) +7.65%
Jul-25-25 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-02-25 02:39PM	AirSculpt Technologies (AIRS) Moves 8.7% Higher: Will This Strength Last? (Zacks)
Jun-16-25 06:45AM	AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown (GlobeNewswire) +11.21%
Jun-11-25 04:05PM	AirSculpt Announces Closing of Offering of Common Stock and Underwriters' Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
Jun-10-25 06:55AM	AirSculpt Announces Pricing of Offering of Common Stock (GlobeNewswire)
Jun-09-25 04:25PM	AirSculpt Announces Public Offering of Common Stock (GlobeNewswire)
May-27-25 12:00PM	AirSculpt Technologies, Inc. (AIRS) is a Great Momentum Stock: Should You Buy? (Zacks)
May-03-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
11:02PM	Loading…
May-02-25 11:02PM	Q1 2025 AirSculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) +33.63% -19.54%
01:12PM	AirSculpt Technologies, Inc. (AIRS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q1 Loss (Zacks)
06:00AM	AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance (GlobeNewswire)
May-01-25 09:32AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q1 2025 Earnings (GuruFocus.com)
Apr-25-25 06:45AM	AirSculpt Technologies Announces First Quarter Fiscal 2025 Earnings Release Date and Conference Call (GlobeNewswire) +7.69%
Apr-17-25 05:27AM	New Strong Sell Stocks for April 17th (Zacks) +6.92%
Apr-14-25 07:18AM	New Strong Sell Stocks for April 14th (Zacks)
Apr-02-25 06:07AM	New Strong Sell Stocks for April 2nd (Zacks)
Apr-01-25 12:16PM	AirSculpt Technologies price target lowered to $2.50 from $6.50 at Leerink (TipRanks) -8.14%
Mar-26-25 05:33AM	New Strong Sell Stocks for March 26th (Zacks)
Mar-24-25 05:29AM	New Strong Sell Stocks for March 24th (Zacks)
Mar-15-25 03:02AM	AirSculpt Technologies Inc (AIRS) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
12:48AM	Q4 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-25 07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Loading…
06:00AM	AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results (GlobeNewswire)
Mar-11-25 09:15AM	Unveiling AirSculpt Technologies (AIRS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks) -11.45%
Mar-06-25 06:45AM	AirSculpt Technologies Announces Fourth Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-13-25 06:45AM	AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 (GlobeNewswire) -19.90%
Jan-07-25 06:45AM	AirSculpt Technologies Announces Participation in the ICR Conference 2025 (GlobeNewswire)
Dec-17-24 06:45AM	AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer (GlobeNewswire) +5.18%
Dec-10-24 10:42PM	Why Is AirSculpt Technologies Inc. (AIRS) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey) -5.67%
Dec-02-24 01:22PM	AirSculpt Technologies, Inc. Announces Opening of Its New White Plains, NY Center (PR Newswire)
Nov-09-24 02:04AM	AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
01:34AM	Q3 2024 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-24 09:30AM	AirSculpt Technologies (AIRS) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +20.72%
07:10AM	AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results (GlobeNewswire)
Nov-07-24 07:09AM	What To Expect From AirSculpt Technologies Inc (AIRS) Q3 2024 Earnings (GuruFocus.com) -6.14%
Nov-05-24 11:17AM	AirSculpt Technologies (AIRS) Moves 14.2% Higher: Will This Strength Last? (Zacks)
Oct-24-24 06:30AM	AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results (GlobeNewswire) +5.26%
Oct-15-24 08:05AM	AirSculpt Technologies (AIRS) Surges 5.6%: Is This an Indication of Further Gains? (Zacks)
Oct-01-24 12:48PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI (PR Newswire) -6.31%
Sep-24-24 01:30PM	AirSculpt Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand (PR Newswire) +7.34%
Sep-19-24 08:32AM	Do Options Traders Know Something About AirSculpt Technologies (AIRS) Stock We Don't? (Zacks) +6.77%
Aug-23-24 08:30AM	Implied Volatility Surging for AirSculpt Technologies (AIRS) Stock Options (Zacks)
Aug-19-24 12:00PM	AirSculpt Technologies, Inc. Announces Opening of Its New Center in Columbus, OH (PR Newswire)
Aug-10-24 08:18AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 10:52AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies (AIRS) Q2 Earnings (Zacks)
07:25AM	AirSculpt Technologies, Inc. (AIRS) Q2 Earnings and Revenues Miss Estimates (Zacks)
06:33AM	AirSculpt Technologies, Inc. (AIRS): The Best Cosmetic Surgery and Aesthetics Stocks To Buy? (Insider Monkey)
06:10AM	AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results (GlobeNewswire)
06:00AM	AirSculpt Technologies Announces Leadership Changes (GlobeNewswire)
Aug-07-24 09:15AM	Ahead of AirSculpt Technologies (AIRS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 06:45AM	AirSculpt Technologies Announces Second Quarter Fiscal 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-17-24 06:00AM	3 Short-Squeeze Stocks to Buy Before July for 20% Returns (InvestorPlace)
May-31-24 09:36AM	Do Options Traders Know Something About AirSculpt (AIRS) Stock We Don't? (Zacks)
May-24-24 09:55AM	Here's Why AirSculpt Technologies (AIRS) Could be Great Choice for a Bottom Fisher (Zacks)
09:35AM	Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround (Zacks)
May-13-24 03:06AM	AirSculpt Technologies Inc (AIRS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-11-24 10:19AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:32PM	AirSculpt Technologies Inc (AIRS) Exceeds First Quarter Revenue Estimates with Strong Performance (GuruFocus.com) -12.06%
01:48PM	AirSculpt Technologies Shares Down After Q1 Adjusted Earnings Fall (MT Newswires)
10:53AM	AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:30AM	Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics (Zacks)
07:15AM	AirSculpt Technologies, Inc. (AIRS) Lags Q1 Earnings and Revenue Estimates (Zacks)
06:00AM	AirSculpt Technologies Reports for First Quarter Earnings (GlobeNewswire)
May-08-24 09:15AM	Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-30-24 07:00AM	AirSculpt Technologies Announces First Quarter 2024 Earnings Release Date and Conference Call (GlobeNewswire)
Apr-29-24 08:30AM	AirSculpt Relocates and Expands to New Location to Meet Market Demand (PR Newswire)
Mar-19-24 08:30AM	AirSculpt Announces Kristen Doute, Star of Bravo's The Valley As Latest AirSculpt Client (PR Newswire)
Mar-18-24 07:00AM	Bear of the Day: AirSculpt (AIRS) (Zacks)
Mar-12-24 03:59PM	Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics (InvestorPlace)
Mar-10-24 10:18AM	10 Botox Alternatives for Smoothing Wrinkles and Anti-Aging Treatment (Insider Monkey)
Mar-07-24 07:00AM	AirSculpt Technologies Announces Participation at BofA Securities Consumer and Retail Conference (GlobeNewswire)
Mar-04-24 08:30AM	AirSculpt Technologies, Inc. Expands Its Scottsdale Location (PR Newswire) -5.10%
Feb-29-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Chemours, Methanex, and AirSculpt and Encourages Investors to Contact the Firm (GlobeNewswire)
Feb-28-24 08:52AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 09:53PM	Q4 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Here's What Key Metrics Tell Us About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
07:10AM	AirSculpt Technologies, Inc. (AIRS) Q4 Earnings and Revenues Miss Estimates (Zacks)
06:36AM	AirSculpt Technologies Inc (AIRS) Reports Strong Revenue and EBITDA Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:00AM	AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023 (GlobeNewswire)
Feb-26-24 07:28PM	AirSculpt Technologies, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire) +7.86%
09:16AM	What Analyst Projections for Key Metrics Reveal About AirSculpt Technologies, Inc. (AIRS) Q4 Earnings (Zacks)
Feb-23-24 09:15AM	Airsculpt shares slide after Fuzzy Panda takes short position (Reuters) -5.65%
Jan-31-24 07:00AM	AirSculpt Technologies Announces Fourth Quarter 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Jan-25-24 12:00PM	What Makes AirSculpt Technologies, Inc. (AIRS) a New Strong Buy Stock (Zacks)
Jan-01-24 09:40AM	Is AirSculpt Technologies (AIRS) Outperforming Other Business Services Stocks This Year? (Zacks)
Dec-19-23 08:34AM	Are Options Traders Betting on a Big Move in AirSculpt (AIRS) Stock? (Zacks)
Nov-11-23 08:42AM	AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 09:54PM	Q3 2023 Airsculpt Technologies Inc Earnings Call (Thomson Reuters StreetEvents) -10.04%
Nov-09-23 07:00PM	AirSculpt Technologies, Inc. (AIRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -9.06%

AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feinstein Adam T	Director	Jun 09 '25	Buy	4.00	1,000,000	4,000,000	14,038,819	Jun 11 05:06 PM
Rollins Aaron	Executive Chairman	May 19 '25	Buy	3.60	2,118	7,629	15,146,039	May 20 04:11 PM
Jashnani Yogesh	Chief Executive Officer	May 07 '25	Buy	2.65	7,000	18,532	464,879	May 07 05:56 PM
Rollins Aaron	Executive Chairman	Nov 15 '24	Sale	6.54	49,019	320,815	14,986,689	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 14 '24	Sale	7.17	44,756	320,677	15,035,708	Nov 15 09:44 PM
Rollins Aaron	Executive Chairman	Nov 13 '24	Sale	7.53	15,438	116,231	15,080,464	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 15 '24	Sale	6.54	24,510	160,411	582,052	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 14 '24	Sale	7.17	22,378	160,338	606,562	Nov 15 09:44 PM
Dean Dennis	Interim CEO and CFO	Nov 13 '24	Sale	7.53	7,719	58,116	628,940	Nov 15 09:44 PM
Dennis Dean	Interim CEO and CFO	Nov 15 '24	Proposed Sale	6.51	2,561	16,672		Nov 15 09:33 PM
Dennis Dean	Interim CEO and CFO	Nov 12 '24	Proposed Sale	7.19	52,046	374,217		Nov 13 02:03 PM
Todd Magazine	Former Officer and Director	Sep 16 '24	Proposed Sale	4.26	76,693	326,932		Oct 25 07:22 PM

TDOC Teladoc Health Inc daily Stock Chart

Peers: AMWL DOCS TVRD HIMS GDRX CLOV OSCR ACHC MD RMTI

| Held by: VTI VB IWM VBK VXF IWN DFAT FNDA VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.19	Insider Own	1.11%	Shs Outstand	176.61M	Perf Week	-1.51%
Market Cap	1.27B	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-5.73%	Shs Float	174.74M	Perf Month	-16.20%
Enterprise Value	1.63B	PEG	-	EPS next Q	-0.26	Inst Own	73.86%	Short Float	13.74%	Perf Quarter	3.16%
Income	-207.36M	P/S	0.50	EPS this Y	80.63%	Inst Trans	4.12%	Short Ratio	3.35	Perf Half Y	-43.34%
Sales	2.54B	P/B	0.89	EPS next Y	29.53%	ROA	-6.46%	Short Interest	24.01M	Perf YTD	-20.90%
Book/sh	8.05	P/C	1.87	EPS next 5Y	55.57%	ROE	-14.18%	52W High	15.21 -52.73%	Perf Year	0.28%
Cash/sh	3.85	P/FCF	4.36	EPS past 3/5Y	-29.04% -33.66%	ROIC	-8.47%	52W Low	6.35 13.23%	Perf 3Y	-81.77%
Dividend Est.	-	EV/EBITDA	8.79	Sales past 3/5Y	8.13% 35.95%	Gross Margin	56.10%	Volatility	3.44% 4.35%	Perf 5Y	-96.17%
Dividend TTM	-	EV/Sales	0.64	EPS Y/Y TTM	79.86%	Oper. Margin	-7.22%	ATR (14)	0.34	Perf 10Y	-75.86%
Dividend Ex-Date	-	Quick Ratio	2.49	Sales Y/Y TTM	-2.57%	Profit Margin	-8.16%	RSI (14)	44.13	Recom	2.62
Dividend Gr. 3/5Y	- -	Current Ratio	2.59	EPS Q/Q	96.23%	SMA20	-1.14%	Beta	1.84	Target Price	9.02
Payout	-	Debt/Eq	0.73	Sales Q/Q	-1.64%	SMA50	-6.63%	Rel Volume	0.49	Prev Close	7.22
Employees	5500	LT Debt/Eq	0.72	Earnings	Jul 29 AMC	SMA200	-17.96%	Avg Volume	7.17M	Price	7.19
IPO	Jul 01, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	26.33% 1.50%	Trades		Volume	3,521,584	Change	-0.42%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-25-25	Initiated	Mizuho	Neutral	$10
Nov-15-24	Initiated	Goldman	Buy	$14
Sep-17-24	Reiterated	Jefferies	Hold	$8 → $10
Feb-29-24	Initiated	Cantor Fitzgerald	Overweight	$22
Feb-26-24	Initiated	Leerink Partners	Market Perform	$17
Jan-17-24	Downgrade	DA Davidson	Buy → Neutral	$33 → $22
Jan-03-24	Initiated	Barclays	Overweight	$26
Apr-12-23	Initiated	Stephens	Equal-Weight	$25
Feb-23-23	Upgrade	SVB Securities	Market Perform → Outperform	$34
Oct-24-22	Upgrade	Guggenheim	Sell → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$35
Aug-17-22	Downgrade	Guggenheim	Neutral → Sell	$25
Aug-12-22	Initiated	DA Davidson	Buy	$45
Aug-02-22	Downgrade	Cowen	Outperform → Market Perform	$58 → $34
Aug-02-22	Downgrade	Berenberg	Buy → Hold	$35
Jul-28-22	Downgrade	Needham	Buy → Hold
Jul-28-22	Downgrade	Goldman	Buy → Neutral	$55 → $36
Jul-06-22	Reiterated	BofA Securities	Neutral	$36 → $42
May-05-22	Downgrade	Argus	Buy → Hold

Show Previous Ratings

Aug-18-25 10:47AM	Teladoc Health expands in Australia with Telecare acquisition (Hospital Management)
05:40AM	Teladoc acquires Australian virtual care firm Telecare (Healthcare Dive)
12:34AM	1 of Wall Street's Favorite Stock Worth Your Attention and 2 We Turn Down (StockStory)
Aug-15-25 01:55PM	Why Teladoc (TDOC) Stock Is Trading Up Today (StockStory)
Aug-14-25 05:00PM	Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health (GlobeNewswire)
12:43PM	Loading…
Aug-13-25 12:43PM	Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? (Zacks) +8.30%
09:45AM	2 Stocks Down More Than 90% That Still Aren't Worth Buying (Motley Fool)
Aug-12-25 12:12PM	Hims & Hers Drives the Consumer-Centric Transformation in Digital Care (Zacks)
01:02AM	TDOC Q2 Deep Dive: Insurance Transition and Product Expansion Shape Outlook (StockStory)
12:44AM	5 Must-Read Analyst Questions From Teladoc's Q2 Earnings Call (StockStory)
Aug-08-25 12:32AM	1 Small-Cap Stock on Our Watchlist and 2 Facing Challenges (StockStory)
Aug-04-25 12:43AM	2 Value Stocks to Consider Right Now and 1 Facing Challenges (StockStory)
Aug-01-25 11:03AM	Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses (Zacks)
Jul-31-25 07:46AM	Teladoc beats Wall Street expectations in Q2 amid strategic revamp (Healthcare Dive)
Jul-30-25 12:16PM	Teladoc (TDOC) Stock Is Up, What You Need To Know (StockStory)
04:08AM	Loading…
04:08AM	Telemedicine Technology Markets Analysis Report 2025 \| Market to Surpass $250 Billion by 2030, Driven by Virtual Consultations, Government Investment, and Emerging AI- and IoT-Powered Care Platforms (GlobeNewswire)
03:17AM	Teladoc Health Inc (TDOC) Q2 2025 Earnings Call Highlights: Strong Integrated Care Growth Amid ... (GuruFocus.com)
Jul-29-25 06:30PM	Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -8.17%
06:05PM	Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:02PM	Teladoc: Q2 Earnings Snapshot (Associated Press Finance)
04:39PM	Teladoc (NYSE:TDOC) Posts Better-Than-Expected Sales In Q2 (StockStory)
04:05PM	Teladoc Health Reports Second Quarter 2025 Results (GlobeNewswire)
09:00AM	Wingspan Raises $24M Series B to Scale Embedded Contractor Management and Capture $1.4T Market (PR Newswire)
Jul-28-25 12:51PM	HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now? (Zacks)
Jul-27-25 11:05PM	Teladoc (TDOC) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-24-25 10:00AM	CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-25 05:28AM	The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well (Zacks)
12:31AM	3 Russell 2000 Stocks We're Skeptical Of (StockStory)
Jul-22-25 12:29PM	Hims & Hers Paves the Way for Global Digital Health Expansion (Zacks)
10:00AM	Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:34AM	Loading…
Jul-18-25 08:34AM	Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? (Zacks)
Jul-17-25 06:15PM	Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:28AM	Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally? (Zacks)
Jul-16-25 04:30PM	Teladoc Health to Announce Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-15-25 11:35PM	Unpacking Q1 Earnings: Teladoc (NYSE:TDOC) In The Context Of Other Online Marketplace Stocks (StockStory)
06:00AM	Teladoc Health Launches Wellbound Employee Assistance Program (EAP) (GlobeNewswire)
05:24AM	Teladoc to launch employee assistance program (Healthcare Dive)
Jul-14-25 12:42AM	2 Momentum Stocks to Research Further and 1 to Be Wary Of (StockStory)
Jul-11-25 06:15PM	Teladoc (TDOC) Dips More Than Broader Market: What You Should Know (Zacks) -5.56%
11:27AM	BofA Remains a Hold on Teladoc Health (TDOC), Sets a PT of $8.75 (Insider Monkey)
Jul-09-25 02:25PM	Teladoc (TDOC) Stock Trades Up, Here Is Why (StockStory)
Jul-03-25 12:01PM	Hims & Hers Enhances Healthcare Through AI-Driven Personalization (Zacks)
10:33AM	OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? (Zacks)
Jul-01-25 06:15PM	Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Jun-25-25 08:30AM	5 Insightful Analyst Questions From Teladoc's Q1 Earnings Call (StockStory) -5.37%
Jun-24-25 04:43PM	Teladoc Stock Is a Coiled Spring That Could Surge Higher. Should You Buy TDOC Here? (Barchart)
02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
Jun-23-25 04:44PM	Teladoc (TDOC) Stock Trades Up, Here Is Why (StockStory) +14.35%
11:07AM	Teladoc Health, Inc. (TDOC): A Bull Case Theory (Insider Monkey)
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
Jun-16-25 06:15PM	Teladoc (TDOC) Rises Higher Than Market: Key Facts (Zacks)
Jun-13-25 06:30AM	What are the top holdings of Cathie Wood's ARK Innovation ETF? (Yahoo Finance Video)
Jun-12-25 05:45AM	M&A to play important role at Teladoc: CEO (Healthcare Dive)
Jun-09-25 06:15PM	Teladoc (TDOC) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
11:44AM	Doximity Declines 4.4% in a Month: How to Play the Stock Now? (Zacks)
08:00AM	Teladoc Health to Participate in Upcoming Investor Conference (GlobeNewswire)
Jun-04-25 08:41AM	Doximity Rides on Telehealth Demand: Will This Drive Sales Further? (Zacks)
Jun-03-25 04:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
Jun-02-25 12:40AM	3 of Wall Street's Favorite Stocks Walking a Fine Line (StockStory)
May-30-25 11:31AM	Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report? (Zacks)
May-23-25 12:33AM	1 Russell 2000 Stock for Long-Term Investors and 2 to Be Wary Of (StockStory)
May-21-25 04:19PM	Hinge Health, MNTN IPOs Test Strength of US Listing Rebound (Bloomberg) -5.04%
May-20-25 07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
May-19-25 12:38AM	3 Value Stocks in Hot Water (StockStory)
May-16-25 10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)
05:30AM	1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid (Motley Fool)
May-08-25 11:39AM	TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit (Zacks)
10:12AM	Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now (Insider Monkey)
May-06-25 09:45AM	Tech That Listens, Learns, and Diagnoses: AI's Breakout Moment in Healthcare (PR Newswire) -5.17%
May-03-25 10:00AM	Teladoc Health: No Real Rescue In Sight (Seeking Alpha)
May-02-25 09:30PM	Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 (GlobeNewswire)
May-01-25 09:05AM	Q1 2025 Teladoc Health Inc Earnings Call (Thomson Reuters StreetEvents)
05:59AM	Teladoc acquires mental health firm UpLift as BetterHelp earnings slide (Healthcare Dive)
03:17AM	Teladoc Health Inc (TDOC) Q1 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Apr-30-25 09:42PM	Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:00PM	Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:24PM	Teladoc: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Teladoc Health Reports First Quarter 2025 Results (GlobeNewswire)
04:01PM	Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits (GlobeNewswire)
12:43PM	Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? (Zacks)
Apr-29-25 03:08AM	Teladoc (TDOC) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-28-25 09:16AM	Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
05:03AM	Online Marketplace Stocks Q4 Teardown: CarGurus (NASDAQ:CARG) Vs The Rest (StockStory)
Apr-25-25 06:15PM	Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why (Zacks)
Apr-21-25 05:29PM	Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? (Insider Monkey) +5.99%
Apr-16-25 06:00PM	Teladoc Health to Announce First Quarter 2025 Financial Results (GlobeNewswire)
11:48AM	Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (Seeking Alpha)
08:43AM	Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it (Zacks)
Apr-12-25 02:05PM	2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction (Motley Fool)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
Apr-08-25 06:15PM	Teladoc (TDOC) Stock Moves -0.97%: What You Should Know (Zacks) +10.06%
06:00AM	Teladoc Health Introduces Next Generation Cardiometabolic Health Program (GlobeNewswire)
Apr-02-25 06:15PM	Teladoc (TDOC) Gains But Lags Market: What You Should Know (Zacks)
Apr-01-25 04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
Mar-30-25 09:30AM	Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? (Motley Fool)
Mar-28-25 11:30AM	Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? (Zacks) -5.49%

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rodrigues Fernando M.	President of BetterHelp	Jun 03 '25	Sale	6.91	4,174	28,842	0	Jun 03 05:37 PM
Rodrigues Fernando M.	President of BetterHelp	Jun 02 '25	Sale	6.86	2,358	16,176	4,174	Jun 03 05:37 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Jun 02 '25	Sale	6.86	5,808	39,843	69,773	Jun 03 05:37 PM
Bliss Kelly	President, U.S. Group Health	Jun 02 '25	Sale	6.86	4,653	31,920	50,266	Jun 03 05:36 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Jun 02 '25	Sale	6.86	13,856	95,052	132,443	Jun 03 05:36 PM
Nueno Carlos	President, International	Jun 02 '25	Sale	6.86	3,958	27,152	17,645	Jun 03 05:36 PM
Rodrigues Fernando M.	Officer	Jun 03 '25	Proposed Sale	6.91	4,174	28,842		Jun 03 10:53 AM
Murthy Mala	Officer	Jun 02 '25	Proposed Sale	6.86	13,856	95,052		Jun 02 03:46 PM
Rodrigues Fernando M.	Officer	Jun 02 '25	Proposed Sale	6.86	2,358	16,176		Jun 02 03:45 PM
Vandervoort Adam C	Officer	Jun 02 '25	Proposed Sale	6.86	5,808	39,843		Jun 02 03:44 PM
Bliss Kelly	Officer	Jun 02 '25	Proposed Sale	6.86	4,653	31,920		Jun 02 03:43 PM
Nueno Carlos	Officer	Jun 02 '25	Proposed Sale	6.86	3,958	27,152		Jun 02 03:38 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Apr 07 '25	Sale	6.81	7,494	51,012	121,467	Apr 08 04:23 PM
Murthy Mala	Officer	Apr 07 '25	Proposed Sale	6.81	7,494	51,012		Apr 07 05:15 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 20 '25	Sale	8.42	20,586	173,416	116,309	Mar 21 04:20 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 20 '25	Sale	8.42	11,011	92,757	64,308	Mar 21 04:20 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 21 '25	Sale	8.00	2,663	21,304	0	Mar 21 04:19 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 20 '25	Sale	8.42	1,503	12,661	2,663	Mar 21 04:19 PM
Bliss Kelly	President, U.S. Group Health	Mar 20 '25	Sale	8.42	9,470	79,775	45,384	Mar 21 04:19 PM
Nueno Carlos	President, International	Mar 20 '25	Sale	8.42	8,266	69,633	12,891	Mar 21 04:19 PM
Rodrigues Fernando M.	Officer	Mar 21 '25	Proposed Sale	8.00	2,663	21,304		Mar 21 10:16 AM
Rodrigues Fernando M.	Officer	Mar 20 '25	Proposed Sale	8.42	1,503	12,661		Mar 20 03:25 PM
Bliss Kelly	Officer	Mar 20 '25	Proposed Sale	8.42	9,470	79,773		Mar 20 03:13 PM
Murthy Mala	Officer	Mar 20 '25	Proposed Sale	8.42	20,586	173,412		Mar 20 03:12 PM
Vandervoort Adam C	Officer	Mar 20 '25	Proposed Sale	8.42	11,011	92,754		Mar 20 03:10 PM
Nueno Carlos	Officer	Mar 20 '25	Proposed Sale	8.42	8,266	69,631		Mar 20 03:09 PM
Rodrigues Fernando M.	President of BetterHelp	Mar 05 '25	Sale	9.20	3,558	32,734	0	Mar 06 04:04 PM
Rodrigues Fernando M.	Officer	Mar 05 '25	Proposed Sale	9.20	3,558	32,734		Mar 05 09:44 AM
Rodrigues Fernando M.	President of BetterHelp	Mar 03 '25	Sale	9.68	1,933	18,719	3,558	Mar 04 04:07 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	9.68	8,630	83,573	99,962	Mar 04 04:07 PM
Nueno Carlos	President, International	Mar 03 '25	Sale	9.68	2,347	22,728	2,932	Mar 04 04:06 PM
Bliss Kelly	President, U.S. Group Health	Mar 03 '25	Sale	9.68	2,904	28,122	35,421	Mar 04 04:06 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Mar 03 '25	Sale	9.68	3,935	38,107	53,919	Mar 04 04:06 PM
Bliss Kelly	Officer	Mar 03 '25	Proposed Sale	9.68	2,904	28,124		Mar 03 04:29 PM
Murthy Mala	Officer	Mar 03 '25	Proposed Sale	9.68	8,630	83,576		Mar 03 04:22 PM
Nueno Carlos	Officer	Mar 03 '25	Proposed Sale	9.68	2,347	22,729		Mar 03 04:21 PM
Rodrigues Fernando M.	Officer	Mar 03 '25	Proposed Sale	9.68	1,933	18,720		Mar 03 04:20 PM
Vandervoort Adam C	Officer	Mar 03 '25	Proposed Sale	9.68	3,935	38,108		Mar 03 04:17 PM
Nanis Nikolaos P.	Officer	Jan 03 '25	Proposed Sale	9.33	502	4,681		Jan 03 05:31 PM
Waters Michael Willem	Officer	Dec 16 '24	Proposed Sale	10.28	4,652	47,823		Dec 16 10:46 AM
Nueno Carlos	President, International	Dec 03 '24	Sale	11.23	2,890	32,455	0	Dec 03 05:30 PM
Nueno Carlos	President, International	Dec 02 '24	Sale	11.93	2,389	28,494	2,890	Dec 03 05:30 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Dec 02 '24	Sale	11.93	4,004	47,756	50,050	Dec 03 05:29 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	11.93	8,783	104,755	92,788	Dec 03 05:28 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 03 '24	Sale	11.07	14,091	156,001	0	Dec 03 05:26 PM
Rodrigues Fernando M.	President of BetterHelp	Dec 02 '24	Sale	11.93	7,873	93,901	14,091	Dec 03 05:26 PM
Bliss Kelly	President, U.S. Group Health	Dec 02 '24	Sale	11.93	2,040	24,331	32,244	Dec 03 05:20 PM
Rodrigues Fernando M.	Officer	Dec 03 '24	Proposed Sale	11.07	14,091	156,002		Dec 03 12:11 PM
Nueno Carlos	Officer	Dec 03 '24	Proposed Sale	11.23	2,890	32,455		Dec 03 11:02 AM
Raman-Tangella Vidya	Officer	Dec 03 '24	Proposed Sale	11.23	468	5,256		Dec 03 09:56 AM
Murthy Mala	Officer	Dec 02 '24	Proposed Sale	11.93	8,783	104,752		Dec 02 04:53 PM
Raman-Tangella Vidya	Officer	Dec 02 '24	Proposed Sale	11.93	1,588	18,940		Dec 02 04:49 PM
Vandervoort Adam C	Officer	Dec 02 '24	Proposed Sale	11.93	4,004	47,754		Dec 02 04:45 PM
Waters Michael Willem	Officer	Dec 02 '24	Proposed Sale	11.93	4,234	50,498		Dec 02 04:41 PM
Nanis Nikolaos P.	Officer	Dec 02 '24	Proposed Sale	11.93	4,218	50,307		Dec 02 04:11 PM
Bliss Kelly	Officer	Dec 02 '24	Proposed Sale	11.93	2,040	24,330		Dec 02 04:08 PM
Nueno Carlos	Officer	Dec 02 '24	Proposed Sale	11.93	2,389	28,493		Dec 02 04:04 PM
Rodrigues Fernando M.	Officer	Dec 02 '24	Proposed Sale	11.93	7,873	93,899		Dec 02 03:25 PM
Verstraete Stephany	Former Officer	Nov 19 '24	Proposed Sale	8.92	75,463	673,130		Nov 19 11:25 AM
Geshuri Arnnon	Former Officer	Nov 15 '24	Proposed Sale	9.21	34,456	317,512		Nov 15 03:32 PM
Geshuri Arnnon	Former Officer	Nov 12 '24	Proposed Sale	9.58	60,000	574,800		Nov 12 02:20 PM
Raman-Tangella Vidya	Officer	Nov 05 '24	Proposed Sale	8.88	1,537	13,649		Nov 05 10:08 AM
Waters Michael Willem	Officer	Nov 04 '24	Proposed Sale	8.67	6,097	52,845		Nov 04 04:50 PM
Geshuri Arnnon	Former Officer	Nov 04 '24	Proposed Sale	8.87	160,278	1,421,691		Nov 04 04:21 PM
Raman-Tangella Vidya	Officer	Nov 04 '24	Proposed Sale	8.67	4,776	41,395		Nov 04 03:55 PM
Verstraete Stephany	Former Officer	Oct 31 '24	Proposed Sale	9.23	16,992	156,755		Oct 31 03:13 PM
Trencher Daniel	Former Officer	Oct 29 '24	Proposed Sale	9.15	18,000	164,739		Oct 29 01:17 PM
Turitz Andrew	Former Officer	Oct 11 '24	Proposed Sale	9.49	38,983	370,102		Oct 11 03:27 PM
Kornwasser Laizer	Former Officer	Oct 09 '24	Proposed Sale	8.90	29,516	262,825		Oct 09 03:16 PM
Trencher Daniel	Former Officer	Oct 08 '24	Proposed Sale	8.58	8,343	71,612		Oct 08 03:22 PM
Turitz Andrew	Former Officer	Oct 08 '24	Proposed Sale	8.58	7,398	63,501		Oct 08 03:21 PM
Bliss Kelly	President, U.S. Group Health	Oct 02 '24	Sale	8.68	897	7,783	28,203	Oct 02 04:13 PM
Nanis Nikolaos P.	Officer	Oct 02 '24	Proposed Sale	8.68	454	3,939		Oct 02 03:20 PM
Bliss Kelly	Officer	Oct 02 '24	Proposed Sale	8.68	897	7,783		Oct 02 03:19 PM
Raman-Tangella Vidya	Officer	Oct 02 '24	Proposed Sale	8.73	14,737	128,654		Oct 02 10:22 AM
Trencher Daniel	Former Officer	Sep 16 '24	Proposed Sale	8.21	9,960	81,773		Sep 16 03:35 PM
MCKINLEY THOMAS	Director	Sep 12 '24	Buy	7.69	4,000	30,756	39,077	Sep 13 05:14 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 04 '24	Sale	7.26	20,773	150,812	20,773	Sep 05 04:05 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 04 '24	Sale	7.26	468	3,398	33,665	Sep 05 04:05 PM
Geshuri Arnnon	CHIEF PEOPLE OFFICER	Sep 03 '24	Sale	7.16	1,795	12,859	44,914	Sep 04 04:13 PM
Murthy Mala	CHIEF FINANCIAL OFFICER	Sep 03 '24	Sale	7.16	8,750	62,685	85,767	Sep 04 04:13 PM
Nanis Nikolaos P.	Chief Technology Officer	Sep 03 '24	Sale	7.16	1,033	7,400	75,410	Sep 04 04:12 PM
Vandervoort Adam C	CHIEF LEGAL OFFICER, SECRETARY	Sep 03 '24	Sale	7.16	2,817	20,181	46,250	Sep 04 04:12 PM
Verstraete Stephany	CHIEF MARKETING OFFICER	Sep 03 '24	Sale	7.16	2,083	14,923	48,843	Sep 04 04:12 PM
Cave James L.	INTERIM CAO	Sep 03 '24	Sale	7.16	555	3,976	13,808	Sep 04 04:12 PM
Trencher Daniel	CHIEF STRATEGY OFFICER	Sep 03 '24	Sale	7.16	1,777	12,730	31,465	Sep 04 04:12 PM
Waters Michael Willem	CHIEF OPERATING OFFICER	Sep 03 '24	Sale	7.16	4,218	30,218	78,309	Sep 04 04:11 PM
Turitz Andrew	EVP, CORPORATE DEVELOPMENT	Sep 03 '24	Sale	7.16	1,617	11,584	41,546	Sep 04 04:11 PM
Raman-Tangella Vidya	CHIEF MEDICAL OFFICER	Sep 03 '24	Sale	7.16	1,114	7,981	34,133	Sep 04 04:11 PM
Raman-Tangella Vidya	Officer	Sep 04 '24	Proposed Sale	7.26	468	3,398		Sep 04 10:25 AM
Turitz Andrew	Officer	Sep 04 '24	Proposed Sale	7.26	20,773	150,812		Sep 04 10:18 AM
Geshuri Arnnon	Officer	Sep 03 '24	Proposed Sale	7.16	1,795	12,859		Sep 03 04:06 PM
Nanis Nikolaos P.	Officer	Sep 03 '24	Proposed Sale	7.16	1,033	7,400		Sep 03 03:54 PM
Murthy Mala	Officer	Sep 03 '24	Proposed Sale	7.16	8,750	62,681		Sep 03 03:49 PM
Verstraete Stephany	Officer	Sep 03 '24	Proposed Sale	7.16	2,083	14,922		Sep 03 03:41 PM
Waters Michael Willem	Officer	Sep 03 '24	Proposed Sale	7.16	4,218	30,216		Sep 03 03:35 PM
Vandervoort Adam C	Officer	Sep 03 '24	Proposed Sale	7.16	2,817	20,180		Sep 03 03:32 PM
Raman-Tangella Vidya	Officer	Sep 03 '24	Proposed Sale	7.16	1,114	7,980		Sep 03 03:27 PM
Trencher Daniel	Officer	Sep 03 '24	Proposed Sale	7.16	1,777	12,730		Sep 03 03:13 PM
Turitz Andrew	Officer	Sep 03 '24	Proposed Sale	7.17	1,617	11,587		Sep 03 03:09 PM

TOI

Oncology Institute Inc

HIMS

Hims & Hers Health Inc

LFMD

LifeMD Inc

AIRS

Airsculpt Technologies Inc

TDOC

Teladoc Health Inc

Upgrade your FINVIZ experience